Interestingly, dysregulated CRYBB2 expression is associated with poor outcomes in prostate cancer patients but correlates with better prognosis in African-American glioblastoma patients with Karnofsky performance score (KPS) ≥ 80. Here, CRYBB2 is linked to prostate cancer.